This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Illinois. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Fadi T Khasawneh: Innovator in Peptide Research
Introduction
Fadi T Khasawneh is a notable inventor based in Rancho Cucamonga, CA (US). He has made significant contributions to the field of peptide research, particularly in the area of G alpha protein signaling. His innovative work has implications for various medical applications.
Latest Patents
Fadi T Khasawneh holds a patent for "Peptides and methods for inhibiting G alpha protein signaling." This patent includes permeable Switch Region I and II peptides that range from 9 to 25 amino acid residues in length. These peptides are specifically designed to inhibit signaling through Gα subunits. Additionally, the patent outlines compositions and methods for inhibiting platelet aggregation and αβ integrin activation using the Switch Region I and II peptides.
Career Highlights
Khasawneh is affiliated with the University of Illinois, where he continues to advance his research in peptide technology. His work has garnered attention for its potential to impact therapeutic strategies in various health conditions.
Collaborations
Fadi T Khasawneh has collaborated with notable colleagues, including Guy C Le Breton and Jin-Sheng Huang. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Fadi T Khasawneh is a distinguished inventor whose work in peptide research is paving the way for new medical advancements. His contributions are vital to understanding and manipulating G alpha protein signaling for therapeutic purposes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile